High levels of PTH in progressive CKD upregulate the receptor activator of nuclear factor-kappa B ligand (RANKL) mRNA and inhibit osteoprotegerin (OPG) gene expression in bone marrow stromal osteoblasts [14], leading to increased quantities of osteoclasts and osteoblasts [15]. The gene discussed is TNFSF11; the disease is chronic kidney disease.